biktarvy at 70% share. the calls are different.

Company: Gilead Sciences

Posted by GileadHIV_Rep_NYC_6621 · March 20, 2026

Tags: field, culture, wlb

not selling anymore.

defending.

relationship maintenance, not convincing.

HIV specialty carries weight people outside it dont see.

when an access denial happens on this population it hits different.

love the territory though.

12 upvotes · 6 comments

More from Gilead Sciences